 |
|
New Cephalosporin Antibiotic— CephaloridineClinical and Laboratory Evaluation
MARVIN TURCK, MD;
DONALD W. BELCHER, MD;
ALLAN RONALD, MD;
RONALD H. SMITH, MD;
JAMES F. WALLACE, MD
Arch Intern Med. 1967;119(1):50-59.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
CEPHALORIDINE, one of the new semisynthetic derivatives of cephalosporin C, is active against a wide variety of pathogenic microorganisms.1-7 Although cephaloridine is chemically related to sodium cephalothin (Keflin), the cephalosporin antibiotic currently in use in the United States, the modification in structure appears to offer some advantages. Results of preliminary studies indicated that cephaloridine possessed greater in vitro activity against some gram-positive strains than sodium cephalothin, consistently demonstrated higher and more sustained antibacterial levels in the blood, and was better tolerated following intramuscular administration 8-11 (and according to written communication from R. S. Griffith, July 1965). This report deals with use of cephaloridine in 86 hospitalized patients treated for a variety of severe infections, and describes its in vitro effects against common bacterial pathogens.
Materials and Methods
Laboratory Studies.
—Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) of cephaloridine and sodium cephalothin were determined with 50 strains each
. . . [Full Text PDF of this Article]
Author Affiliations
SEATTLE, WASH
From the Department of Medicine, University of Washington School of Medicine and King County Hospital, Seattle.
Footnotes
Received for publication June 9, 1966; accepted Sept 29.
Reprint requests to King County Hospital, 325 9th Ave, Seattle 98104 (Dr. Turck).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
